274 related articles for article (PubMed ID: 20980437)
1. CDK9 regulates AR promoter selectivity and cell growth through serine 81 phosphorylation.
Gordon V; Bhadel S; Wunderlich W; Zhang J; Ficarro SB; Mollah SA; Shabanowitz J; Hunt DF; Xenarios I; Hahn WC; Conaway M; Carey MF; Gioeli D
Mol Endocrinol; 2010 Dec; 24(12):2267-80. PubMed ID: 20980437
[TBL] [Abstract][Full Text] [Related]
2. Androgen receptor serine 81 phosphorylation mediates chromatin binding and transcriptional activation.
Chen S; Gulla S; Cai C; Balk SP
J Biol Chem; 2012 Mar; 287(11):8571-83. PubMed ID: 22275373
[TBL] [Abstract][Full Text] [Related]
3. Selective inhibition reveals cyclin-dependent kinase 2 as another kinase that phosphorylates the androgen receptor at serine 81.
Jorda R; Bučková Z; Řezníčková E; Bouchal J; Kryštof V
Biochim Biophys Acta Mol Cell Res; 2018 Feb; 1865(2):354-363. PubMed ID: 29157894
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylation of the androgen receptor at Ser81 is co-sustained by CDK1 and CDK9 and leads to AR-mediated transactivation in prostate cancer.
Gao X; Liang J; Wang L; Zhang Z; Yuan P; Wang J; Gao Y; Ma F; Calagua C; Ye H; Voznesensky O; Wang S; Wang T; Liu J; Chen S; Liu X
Mol Oncol; 2021 Jul; 15(7):1901-1920. PubMed ID: 33932081
[TBL] [Abstract][Full Text] [Related]
5. Positive feedback loop mediated by protein phosphatase 1α mobilization of P-TEFb and basal CDK1 drives androgen receptor in prostate cancer.
Liu X; Gao Y; Ye H; Gerrin S; Ma F; Wu Y; Zhang T; Russo J; Cai C; Yuan X; Liu J; Chen S; Balk SP
Nucleic Acids Res; 2017 Apr; 45(7):3738-3751. PubMed ID: 28062857
[TBL] [Abstract][Full Text] [Related]
6. Flavopiridol induces phosphorylation of AKT in a human glioblastoma cell line, in contrast to siRNA-mediated silencing of Cdk9: Implications for drug design and development.
Caracciolo V; Laurenti G; Romano G; Carnevale V; Cimini AM; Crozier-Fitzgerald C; Gentile Warschauer E; Russo G; Giordano A
Cell Cycle; 2012 Mar; 11(6):1202-16. PubMed ID: 22391209
[TBL] [Abstract][Full Text] [Related]
7. Cyclin-dependent kinase 9 is required for tumor necrosis factor-alpha-stimulated matrix metalloproteinase-9 expression in human lung adenocarcinoma cells.
Shan B; Zhuo Y; Chin D; Morris CA; Morris GF; Lasky JA
J Biol Chem; 2005 Jan; 280(2):1103-11. PubMed ID: 15528190
[TBL] [Abstract][Full Text] [Related]
8. T-loop phosphorylated Cdk9 localizes to nuclear speckle domains which may serve as sites of active P-TEFb function and exchange between the Brd4 and 7SK/HEXIM1 regulatory complexes.
Dow EC; Liu H; Rice AP
J Cell Physiol; 2010 Jul; 224(1):84-93. PubMed ID: 20201073
[TBL] [Abstract][Full Text] [Related]
9. The CDK9/cyclin T1 subunits of P-TEFb in mouse oocytes and preimplantation embryos: a possible role in embryonic genome activation.
Oqani RK; Kim HR; Diao YF; Park CS; Jin DI
BMC Dev Biol; 2011 Jun; 11():33. PubMed ID: 21639898
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of cdk9 during herpes simplex virus 1 infection impedes viral transcription.
Ou M; Sandri-Goldin RM
PLoS One; 2013; 8(10):e79007. PubMed ID: 24205359
[TBL] [Abstract][Full Text] [Related]
11. Dasatinib inhibits site-specific tyrosine phosphorylation of androgen receptor by Ack1 and Src kinases.
Liu Y; Karaca M; Zhang Z; Gioeli D; Earp HS; Whang YE
Oncogene; 2010 Jun; 29(22):3208-16. PubMed ID: 20383201
[TBL] [Abstract][Full Text] [Related]
12. The functional role of an interleukin 6-inducible CDK9.STAT3 complex in human gamma-fibrinogen gene expression.
Hou T; Ray S; Brasier AR
J Biol Chem; 2007 Dec; 282(51):37091-102. PubMed ID: 17956865
[TBL] [Abstract][Full Text] [Related]
13. CDK9 inhibition strategy defines distinct sets of target genes.
Garriga J; Graña X
BMC Res Notes; 2014 May; 7():301. PubMed ID: 24886624
[TBL] [Abstract][Full Text] [Related]
14. Up-regulation of CDK9 kinase activity and Mcl-1 stability contributes to the acquired resistance to cyclin-dependent kinase inhibitors in leukemia.
Yeh YY; Chen R; Hessler J; Mahoney E; Lehman AM; Heerema NA; Grever MR; Plunkett W; Byrd JC; Johnson AJ
Oncotarget; 2015 Feb; 6(5):2667-79. PubMed ID: 25596730
[TBL] [Abstract][Full Text] [Related]
15. Androgen receptor interacts with the positive elongation factor P-TEFb and enhances the efficiency of transcriptional elongation.
Lee DK; Duan HO; Chang C
J Biol Chem; 2001 Mar; 276(13):9978-84. PubMed ID: 11266437
[TBL] [Abstract][Full Text] [Related]
16. Androgen-dependent regulation of Her-2/neu in prostate cancer cells.
Berger R; Lin DI; Nieto M; Sicinska E; Garraway LA; Adams H; Signoretti S; Hahn WC; Loda M
Cancer Res; 2006 Jun; 66(11):5723-8. PubMed ID: 16740710
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of CDK9 activity compromises global splicing in prostate cancer cells.
Hu Q; Poulose N; Girmay S; Helevä A; Doultsinos D; Gondane A; Steele RE; Liu X; Loda M; Liu S; Tang DG; Mills IG; Itkonen HM
RNA Biol; 2021 Nov; 18(sup2):722-729. PubMed ID: 34592899
[TBL] [Abstract][Full Text] [Related]
18. The structure of P-TEFb (CDK9/cyclin T1), its complex with flavopiridol and regulation by phosphorylation.
Baumli S; Lolli G; Lowe ED; Troiani S; Rusconi L; Bullock AN; Debreczeni JE; Knapp S; Johnson LN
EMBO J; 2008 Jul; 27(13):1907-18. PubMed ID: 18566585
[TBL] [Abstract][Full Text] [Related]
19. P-TEFb kinase complex phosphorylates histone H1 to regulate expression of cellular and HIV-1 genes.
O'Brien SK; Cao H; Nathans R; Ali A; Rana TM
J Biol Chem; 2010 Sep; 285(39):29713-20. PubMed ID: 20551309
[TBL] [Abstract][Full Text] [Related]
20. Attenuation of androgen receptor-dependent transcription by the serine/threonine kinase Pim-1.
Thompson J; Peltola KJ; Koskinen PJ; Jänne OA; Palvimo JJ
Lab Invest; 2003 Sep; 83(9):1301-9. PubMed ID: 13679438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]